Putting Science to Work

Archives / 2019 / February

  • Syngene Q3 net profit up 6 pc to Rs 87 cr

    Business Standard- 22/01/2019. Consolidated total revenue of the company stood at Rs 484.4 crore for the quarter under consideration as against Rs 399.3 crore for the same period a year ago.


Discovery Chemistry Discovery Biology Safety Assessment Large Molecule Development Chemical Development Formulation Development Stability Studies Polymer Research Integrated Discovery & Development Clinical Development Services Bioinfomatics Antibody Drug Conjugates Oligonucleotide Synthesis Contact Us

This site is best viewed in Firefox (29+), Chrome (35+), or Microsoft Internet Explorer (9+)

Social Widget